Literature DB >> 6112271

Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjögren's syndrome.

A J Crisp, B I Hoffbrand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6112271      PMCID: PMC1440042          DOI: 10.1177/014107688007300114

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

Authors:  D ALARCON SEGOVIA; T HERSKOVIC; W H DEARING; L G BARTHOLOMEW; J C CAIN; R G SHORTER
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

Review 2.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

3.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

4.  [Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)].

Authors:  B H Jaup
Journal:  Dtsch Med Wochenschr       Date:  1978-07-28       Impact factor: 0.628

5.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

  5 in total
  6 in total

Review 1.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

2.  Sulphasalazine-induced cerebral lupus erythematosus.

Authors:  P Rafferty; A C Young; M R Haeney
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

3.  Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

Authors:  K Wildhagen; K Hartung; M Hammer; W Mau; R E Schmidt; H Deicher; H Zeidler
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

4.  Sulphasalazine-induced systemic lupus erythematosus in a child.

Authors:  B A Vanheule; F Carswell
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

Review 5.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

6.  Sensorimotor neuropathy with sulphasalazine.

Authors:  T R Price
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.